Balazs EA, Denlinger JL., Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993; 39: 3–9.
Zhang W, Doherty M, Arden N, et al. EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669–681.
Bruyère O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum 2019; 49: 337–350.
Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019; 27: 1578–1589.
Steinmeyer J, Bock F, Stöve J, et al. Pharmacological treatment of knee osteoarthritis: special considerations of the new German guideline. Orthop Rev (Pavia) 2018; 10: 7782.
Sellam J, Courties A, Eymard F, et al. Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis. Joint Bone Spine 2020; 87: 548–555.
Abdulla A, Adams N, Bone M, et al; British Geriatric Society. Guidance on the management of pain in older people. Age Ageing 2013; 42(Suppl. 1): i1–i57.
Trojian TH, Concoff AL, Joy SM, et al. AMSSM scientific statement concerning viscosupplementation injections for knee osteoarthritis: importance for individual patient outcomes. Br J Sports Med 2016; 50: 84–92.
Newberry SJ, Fitzgerald JD, Maglione MA, et al. Systematic review for effectiveness of hyaluronic acid in the treatment of severe Degenerative Joint Disease (DJD) of the knee [Internet]. Rockville, MD: Agency for Healthcare Research and Quality (US), 2015.
Strand V, McIntyre LF, Beach WR, et al. Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials. J Pain Res 2015; 8: 217–228.
Bannuru RR, Schmid CH, Kent DM, et al. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med 2015; 162: 46–54.
Richette P, Chevalier X, Ea HK, et al. Hyaluronan for knee osteoarthritis: an updated meta-analysis of trials with low risk of bias. RMD Open 2015; 1: e000071.
Xing D, Wang B, Liu Q, et al. Intra-articular hyaluronic acid in treating knee osteoarthritis: a PRISMA- compliant systematic review of overlapping meta-analysis. Sci Rep 2016; 6: 32790.
Bannuru RR, Natov NS, Obadan IE, et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 2009; 61: 1704–1711.
He WW, Kuang MJ, Zhao J, et al. Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: a meta-analysis. Int J Surg 2017; 39: 95–103.
Chevalier X, Sheehan B, Whittington C, et al. Efficacy and safety of hylan G-F 20 versus intra-articular corticosteroids in people with knee osteoarthritis: a systematic review and network meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord 2020; 13: 1179544120967370.
O’Hanlon CE, Newberry SJ, Booth M, et al. Hyaluronic acid injection therapy for osteoarthritis of the knee: concordant efficacy and conflicting serious adverse events in two systematic reviews. Syst Rev 2016; 5: 186.
Altman R, Lim S, Steen RG, et al. Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: evidence from a large U.S. health claims database. PLoS One 2015; 10: e0145776.
Altman R, Fredericson M, Bhattacharyya SK, et al. Association between hyaluronic acid injections and time-to-total knee replacement surgery. J Knee Surg 2016; 29: 564–570.
Etter K, Chitnis AS, Holy CE, et al. High-concentration nonavian high-molecular weight hyaluronan injections and time-to-total knee replacement surgery. J Comp Eff Res 2020; 9: 795–805.
Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2020; 72: 149–162.
Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg 2013; 21: 571–576.
Jevsevar DS, Shores PB, Mullen K, et al. Mixed treatment comparisons for nonsurgical treatment of knee osteoarthritis: a network meta-analysis. J Am Acad Orthop Surg 2018; 26: 325–336.
Meiyappan KP, Cote MP, Bozic KJ, et al. Adherence to the American Academy of Orthopaedic Surgeons clinical practice guidelines for nonoperative management of knee osteoarthritis. J Arthroplasty 2020; 35: 347–352.
Carlson VR, Ong AC, Orozco FR, et al. Compliance with the AAOS guidelines for treatment of osteoarthritis of the knee: a survey of the American Association of Hip and Knee Surgeons. J Am Acad Orthop Surg 2018; 26: 103–107.
Printz JO, Lee JJ, Knesek M, et al. Conflict of interest in the assessment of hyaluronic acid injections for osteoarthritis of the knee: an updated systematic review. J Arthroplasty 2013; 28(Suppl. 8): 30–33.e1.
Nicholls MA, Fierlinger A, Niazi F, et al. The disease-modifying effects of hyaluronan in the osteoarthritic disease state. Clin Med Insights Arthritis Musculoskelet Disord 2017; 10: 1179544117723611.
Altman RD, Manjoo A, Fierlinger A, et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord 2015; 16: 321.
Bhadra AK, Altman R, Dasa V, et al. Appropriate use criteria for hyaluronic acid in the treatment of knee osteoarthritis in the United States. Cartilage 2017; 8: 234–254.
Henrotin Y, Raman R, Richette P, et al. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. Semin Arthritis Rheum 2015; 45: 140–149.
Raman R, Henrotin Y, Chevalier X, et al. Decision algorithms for the retreatment with viscosupplementation in patients suffering from knee osteoarthritis: recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO). Cartilage 2018; 9: 263–275.
Henrotin Y, Chevalier X, Raman R, et al. EUROVISCO guidelines for the design and conduct of clinical trials assessing the disease-modifying effect of knee viscosupplementation. Cartilage 2020: 11: 60–70.
Conrozier T, Monfort J, Chevalier X, et al. EUROVISCO recommendations for optimizing the clinical results of viscosupplementation in osteoarthritis. Cartilage 2020: 11: 47–59.
Altman R, Hackel J, Niazi F, et al. Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: a systematic review. Semin Arthritis Rheum 2018; 48: 168–175.
Tubach F, Ravaud P, Martin-Mola E, et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res 2012; 64: 1699–1707.
Roos EM, Roos HP, Lohmander LS, et al. Knee Injury and Osteoarthritis Outcome Score [KOOS]–development of a self-administered outcome measure. J Orthop Sports Phys Ther 1998; 28: 88–96.
Pham T, Van Der Heijde D, Lassere M, et al. Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria. J Rheumatol 2003; 30: 1648–1654.
Steinmeyer J, Bock F, Stöve J, et al. Pharmacological treatment of knee osteoarthritis: special considerations of the new German guideline. Orthop Rev (Pavia) 2018; 10: 7782.